Corporate and state-backed investment firm High-Tech Gründerfonds and the investment company of Life Science Inkubator have joined with the TTHU [Technology Transfer Heinrich Heine University GmbH] and an undiclsosed private investor, backing Germany-based cancer diagnostics company Epivios.

Epivios is a spin-off from the Heinrich Heine University of Düsseldorf.

Ron Winker, Investment Manager at High Tech Gründerfonds, said:  “With future developments by Epivios, a new approach to analysis will greatly increase the validity of cancer-relevant diagnostics. The platform-based nature of the procedure yields an attractive market potential, also with regard to further indications.”

Jörg Fregien, Managing Director of LSI Pre-Seed Fund, said: “We are delighted that it has been possible – especially considering the current difficult financing situation– to implement a cooperative project with HTGF for the first time.”

Stefanie Niemann, director of the TTHU and Head of Research Management at the Heinrich Heine University of Düsseldorf, said: “I am very…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?